We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current CERS market cap is 300.93M. The company's latest EPS is USD -0.2068 and P/E is -8.03.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 46.34M | 25.05M | 38.48M | 55.23M | 47.25M |
| Operating Income | -7.45M | -37.95M | -14.15M | -4.14M | -5.24M |
| Net Income | -8.48M | -13.62M | -15.62M | -13.28M | -7.27M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 93.77M | 114.25M | 159.52M | 162.05M | 186.8M |
| Operating Income | -66.23M | -58.33M | -48.94M | -62.08M | -30.05M |
| Net Income | -71.24M | -59.86M | -54.37M | -42.78M | -37.49M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 215.4M | 218.09M | 209.34M | 198.86M | 205.84M |
| Total Liabilities | 141.33M | 149.53M | 149.77M | 147.17M | 156.82M |
| Total Equity | 74.07M | 68.56M | 59.56M | 51.69M | 49.02M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 165.54M | 221.42M | 237.5M | 218.09M | 197.75M |
| Total Liabilities | 108.48M | 117.61M | 151.88M | 149.53M | 144.3M |
| Total Equity | 57.05M | 103.81M | 85.62M | 68.56M | 53.44M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -23.86M | -25.62M | -8.5M | -17.5M | -27.99M |
| Investing | 1.08M | 8.46M | -1.65M | 683k | 408k |
| Financing | 3.74M | 4.19M | 2.06M | 1.89M | 9.49M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -65.84M | -40.74M | -33.92M | -25.62M | -43.17M |
| Investing | 28.19M | -49.56M | 12.69M | 8.46M | 8.62M |
| Financing | 43.49M | 91.78M | 34.29M | 4.19M | 10.67M |
| Market Cap | 300.93M |
| Price to Earnings Ratio | -8.03 |
| Price to Sales Ratio | 1.61 |
| Price to Cash Ratio | 25.86 |
| Price to Book Ratio | 5.63 |
| Dividend Yield | - |
| Shares Outstanding | 181.28M |
| Average Volume (1 week) | 787.85k |
| Average Volume (1 Month) | 942.75k |
| 52 Week Change | -31.40% |
| 52 Week High | 3.08 |
| 52 Week Low | 1.205 |
| Spread (Intraday) | 0.16 (9.36%) |
| Company Name | Cerus Corp |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.cerus.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
